| Literature DB >> 28245883 |
Nadine Rujeni1, Domenica Morona2, Eugene Ruberanziza3, Humphrey D Mazigo4.
Abstract
Even though Rwanda lies within a region that has a high prevalence of schistosomiasis and soil-transmitted helminth (STH) infections, epidemiological information regarding these infections in the country remains scarce. The present review attempts to compile the available data on schistosomiasis and STHs, from 1940 to 2014, to provide an insight on the epidemiological profile of these infections. This information will, in turn, support the design and implementation of sustainable control measures. The available records indicate that only Schistosoma mansoni and all the major species of STHs are endemic in Rwanda. In 2008, the national prevalence of S. mansoni was reported to be 2.7%, ranging from 0 to 69.5%, and that of STH infections was 65.8% (diagnosed using the Kato-Katz technique). The prevalence of these infections varies from one district to another, with schoolchildren remaining a highly affected group. The main control approach is mass drug administration using albendazole and praziquantel, mostly targeting school-aged children in school environments. In 2008, adult individuals living in areas with a prevalence of S. mansoni ≥30% were also included in the mass drug administration programme. However, despite Rwanda achieving an almost 100% coverage of this programme in 2008-2010, the transmission of S. mansoni and STHs continues to take place, as illustrated by the most recent surveys. If Rwanda is to achieve sustainable control and elimination of schistosomiasis and STHs, there is a need to revise the country's control strategy and adopt an integrated control approach that involves a combination of measures.Entities:
Keywords: Control; Epidemiology; Rwanda; Schistosomiasis; Soil-transmitted helminths
Mesh:
Substances:
Year: 2017 PMID: 28245883 PMCID: PMC5331630 DOI: 10.1186/s40249-016-0212-z
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Epidemiological studies reporting on the prevalence and intensity of infection of schistosomiasis and STHs in Rwanda
| Authors | Parasites | Major findings | Geographical area |
|---|---|---|---|
| [ | Soil-transmitted helminths-hookworm, | A total of 8 313 randomly sampled school children from 136 schools in 30 districts in Rwanda. Single stool sample collected from each school child and processed using Kato-Katz method and urine filtration test for detection of | All geographical areas of Rwanda |
|
|
| ||
| [ |
| A total of 4 751 individuals aged 0- > 30 years were examined single feacal smear on single stool sample. Of these 107 (2.17%) from north and 69 (3.47%) had | Bulera south and north |
| A total of 5 739 individuals aged 0- > 30 years were examined using single feacal smear on single stool sample. Of these 5.9% (135) from north and 236 (6.8%) had | Ruhondo south and north | ||
| [ |
| A total of 1 605 individuals, 1485 children aged 5-17 and 120 adolescent aged 18–20 years were screening using Kato Katz techniques on duplicated thick smears prepared from single stool sample. Of all the individuals, 0.25, 0.75, 2.8 and 6.04% were infected with | Lake Bulera and Ruhondo, Musanze district |
| [ |
| A total of 270 individuals (children and adults) were screened using duplicated Kato Katz thick smears technique on single stool sample. Of these participants, 20.1% were infected with variation of prevalence between villages ranging from 1.6 to 30.1%. | Lake Rweru, Bugesera district |
| STH | The prevalence of hookworm was 33%, 22% for | ||
| [ |
| A total of 311 school children from four primary school were examined for presence of | Nkombo island, Lake Kivu, Rusizi district |
| [ | STH | A total of 662 school children (301 from rural and 321 from urban) with median age of 10.2 years. Stool sample were examined using Polymerase Chain Reaction (PCR) and the overall prevalence of STH was 13% in urban and 38% in rural areas. | Butare and Huye district, southern province |
Fig. 1Distribution of schistosomiasis in Rwanda. Map shows maximum point prevalence of schistosome infections and locations of S. mansoni and S. haematobium surveys in Rwanda. (http://www.thiswormyworld.org/maps/2013/distribution-of-schistosomiasis-survey-data-in-rwanda)
Fig. 2Distribution of STHs in Rwanda. The map shows the maximum point prevalence of STH infections and locations of STH surveys in Rwanda. http://www.thiswormyworld.org/maps/by-worm/soil-transmitted-helminths
Fig. 3Schistosomiasis treatment coverage for the period 2008–2009 among SAC in Rwanda. Preventive Chemotherapy (PC)- population requiring preventive chemotherapy for schistosomiasis refers to estimates of the number of children needing preventive chemotherapy and the number of treatments for a given period. National coverage refers to the proportion (%) of individuals in the population requiring preventive chemotherapy against schistosomiasis who have been treated
Fig. 4Treatment coverage for STHs for the period 2005–2010 among SAC in Rwanda No data were available on treatment coverage and national coverage for the period of 2005–2007 among SAC. Preventive Chemotherapy (PC)- population requiring preventive chemotherapy for schistosomiasis refers to estimates of the number of children needing preventive chemotherapy and number of treatments for a given period. National coverage refers to the proportion (%) of individuals in the population requiring preventive chemotherapy against schistosomiasis who have been treated
Implementation of preventive chemotherapy for the period 2006–2010 using ALB/MEB against STHs among PreSAC and SAC in Rwanda
| 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|
| PreSAC | PreSAC | PreSAC/SAC | PreSAC/SAC | PreSAC/SAC | |
| Round 1 | |||||
| Population targeted | 1 105 847 | 1 127 484 | 3 895 451 | - | - |
| Population treated | 1 193 428 | 1 185 814 | 3 580 726 | 4 088 084 | 4 129 227 |
| Geographical coverage | 100% | - | - | ||
| Programme coverage | 107.9% | 105.2% | 91.9% | - | - |
| Round 2 | |||||
| Population targeted | 1 127 484 | ||||
| Population treated | 1 158 318 | 2 094 325 | |||
| Geographical coverage | - | - | |||
| Programme coverage | 102.7% | ||||
○ Geographical coverage - proportion (%) of endemic districts covered with preventive chemotherapy
○ Programme coverage - proportion (%) of individuals who were treated as per the programme target
○ PreSAC- Pre-school Aged Children
○ SAC- School Aged Children
Implementation of preventive chemotherapy in 2014 using ALB/MEB/PZQ against STHs and schistosomiasis among PreSAC and SAC in Rwanda
| Age group | Type of worm infection | Population requiring preventive chemotherapy | Number of children targeted | Reported number treated | Programme coverage | National coverage |
|---|---|---|---|---|---|---|
| Pre-SAC | Round 1- Albendazole/mebendazole | |||||
| STH | 948,314 | 1,295,177 | 1,252,185 | 96.68% | 100% | |
| Round 2- Albendazole/mebendazole | ||||||
| 948,314 | 1,295,177 | 1,241,007 | 95.82% | 100% | ||
| School aged children | Schistosomiasis/STH | Round-1 Albendazole/Praziquantel | ||||
| 2,326,209 | 177,688 | 174,762 | 98.35% | 7.51% | ||
| Round-2 Albendazole/mebendazole | ||||||
| 2,326,209 | 3,177,065 | 3,026,425 | 95.26% | 100% | ||